4.7 Review

The role of fat and inflammation in the pathogenesis and management of osteoarthritis

Journal

RHEUMATOLOGY
Volume 57, Issue -, Pages 10-21

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kex399

Keywords

adipokines; inflammation; infrapatellar fat pad; obesity; osteoarthritis

Categories

Ask authors/readers for more resources

OA is a complex disease involving mechanical, metabolic and inflammatory contributions to its aetiology. A key risk factor, obesity, is becoming an increasing focus of research due to its multiple potential impacts on OA incidence, progression and symptom severity. An increased load due to an increase in body mass has been well established as a mechanical contribution to the pathophysiology of OA. However, evidence of obesity-linked to OA in non-weight-bearing joints has implicated the biological role of adipose inflammation and metabolic abnormalities in OA. The identification of inflammatory mediators such as adipokines (adipose-derived molecules) in OA has further incriminated the role of adiposity. This narrative review aims to discuss the role of adipose-derived inflammation in OA, with a focus on the contrast between systemic and local adipose tissue, and potential treatment applications targeting the adipo-inflammatory aspects of the disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

OATargets: a knowledge base of genes associated with osteoarthritis joint damage in animals

Jamie Soul, Matthew J. Barter, Christopher B. Little, David A. Young

Summary: The study identified 459 genes modulated in animal models of OA, with ageing and post-traumatic models being the most prominent. Ninety-eight of the 143 genes genetically modulated more than once had a consistent effect on OA joint damage severity. By expanding existing annotations and prioritising promising therapeutic targets, the study validated the associations using the latest reported data.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Orthopedics

Long-term Effect of a Single Subcritical Knee Injury: Increasing the Risk of Anterior Cruciate Ligament Rupture and Osteoarthritis

Carina L. Blaker, Sanaa Zaki, Christopher B. Little, Elizabeth C. Clarke

Summary: This study in mice found that subcritical knee injury can lead to specific joint tissue pathologies (osteochondral lesions and progressive weakening of the ACL) and allodynic sensitization, indicating a predisposition for secondary critical injuries (such as ACL rupture) and an increased risk of PTOA onset and progression.

AMERICAN JOURNAL OF SPORTS MEDICINE (2021)

Article Biophysics

Sex- and injury-based differences in knee biomechanics in mouse models of post-traumatic osteoarthritis

Carina L. Blaker, Dylan M. Ashton, Nathan Doran, Christopher B. Little, Elizabeth C. Clarke

Summary: Sex and joint injury play important roles in the onset and progression of osteoarthritis. This study evaluated passive anterior-posterior knee biomechanics in male and female mice, finding that joint laxity was comparable between sexes but joint stiffness was greater in females. The anterior-posterior joint mechanics were significantly affected by the loss of the ACL, regardless of the injury model used.

JOURNAL OF BIOMECHANICS (2021)

Article Cell & Tissue Engineering

Generation of a miR-26b stem-loop knockout human iPSC line, MCRIi019-A-1, using CRISPR/Cas9 editing

Louise H. W. Kung, Lisa Sampurno, Christopher B. Little, Shireen R. Lamande, John F. Bateman

Summary: miR-26b is implicated in various human diseases, and a homozygous miR-26b stem-loop knockout human iPSC line has been generated and characterized in this study. This gene-edited iPSC line exhibits normal karyotype, pluripotency markers, and differentiation potential, making it valuable for investigating disease mechanisms and therapeutic strategies in vitro.

STEM CELL RESEARCH (2021)

Review Biochemistry & Molecular Biology

Extracellular Vesicles from Mesenchymal Stromal Cells for the Treatment of Inflammation-Related Conditions

Sean T. Ryan, Elham Hosseini-Beheshti, Dinara Afrose, Xianting Ding, Binbin Xia, Georges E. Grau, Christopher B. Little, Lana McClements, Jiao Jiao Li

Summary: MSC-derived EVs have shown therapeutic potential for treating inflammation-related conditions and have demonstrated efficacy in studies. They can serve as anti-inflammatory and pro-regenerative agents for diseases like osteoarthritis, rheumatoid arthritis, and Alzheimer's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Orthopedics

OA foundations- experimental models of osteoarthritis

S. Zaki, C. L. Blaker, C. B. Little

Summary: Osteoarthritis is a disease with diverse phenotypes, and the selection and use of animal models in research should align with patient sub-types. This review discusses the importance of selecting animal models based on study objectives, alignment with sub-types, and available resources. It also proposes an experimental design checklist for choosing the optimal model.

OSTEOARTHRITIS AND CARTILAGE (2022)

Review Chemistry, Medicinal

The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date

Win Min Oo, Christopher Little, Vicky Duong, David J. Hunter

Summary: This review discusses the need for disease modifying drugs (DMOADs) for the management of osteoarthritis (OA), the classification of clinical phenotypes or molecular/mechanistic endotypes for targeted drug discovery, and summarizes the efficacy and safety of targeted drugs in Phase 2 and 3 clinical trials targeting cartilage-driven, bone-driven, and inflammation-driven endotypes. The reasons for failures in OA clinical trials and possible steps to overcome these barriers are also briefly presented.

DRUG DESIGN DEVELOPMENT AND THERAPY (2021)

Editorial Material Orthopedics

Prevention and early treatment, a future focus for OA research

E. M. Roos, M. A. Risberg, C. B. Little

OSTEOARTHRITIS AND CARTILAGE (2021)

Review Orthopedics

Metformin as a potential disease-modifying drug in osteoarthritis: a systematic review of pre-clinical and human studies

Y. Z. Lim, Y. Wang, M. Estee, J. Abidi, M. Udaya Kumar, S. M. Hussain, A. E. Wluka, C. B. Little, F. M. Cicuttini

Summary: Objective: This study systematically reviewed the potential disease-modifying effect of metformin in osteoarthritis based on evidence from pre-clinical and human studies. The results suggest that metformin has chondroprotective, immunomodulatory, and analgesic effects in osteoarthritis, supported by consistent findings in pre-clinical and human studies. Further high-quality clinical trials are needed to confirm these findings.

OSTEOARTHRITIS AND CARTILAGE (2022)

Editorial Material Cell & Tissue Engineering

THE BENEFITS AND COSTS OF REDUCING VARIABILITY

C. B. Little, S. Zaki, C. L. Blaker, E. C. Clarke

BONE & JOINT RESEARCH (2022)

Article Orthopedics

Challenging the Perceptions of Human Tendon Allografts: Influence of Donor Age, Sex, Height, and Tendon on Biomechanical Properties

Dylan M. Ashton, Carina L. Blaker, Nicholas Hartnell, Patrick Haubruck, Samantha A. Hefferan, Christopher B. Little, Elizabeth C. Clarke

Summary: This study investigated the mechanical properties of a range of human lower leg tendons and their relationship with donor age, sex, and height. The results showed significant differences in mechanical properties among different tendons, with relatively small effects of donor characteristics limited to specific tendons. The findings challenge the exclusion of donors aged >65 years in all tendon grafts, as age only negatively affected the properties of the Achilles tendon (maximum load).

AMERICAN JOURNAL OF SPORTS MEDICINE (2023)

Article Multidisciplinary Sciences

Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis

Jia Q. Ng, Toghrul H. Jafarov, Christopher B. Little, Tongtong Wang, Abdullah M. Ali, Yan Ma, Georgette A. Radford, Laura Vrbanac, Mari Ichinose, Samuel Whittle, David J. Hunter, Tamsin R. M. Lannagan, Nobumi Suzuki, Jarrad M. Goyne, Hiroki Kobayashi, Timothy C. Wang, David R. Haynes, Danijela Menicanin, Stan Gronthos, Daniel L. Worthley, Susan L. Woods, Siddhartha Mukherjee

Summary: Osteoarthritis is characterized by irreversible degeneration of articular cartilage. Gremlin 1 marks a bipotent cell population on the articular surface, which plays a crucial role in chondrogenic and osteogenic progenitor cells. These cells are affected by injury and aging, leading to the development of osteoarthritis.

NATURE COMMUNICATIONS (2023)

Review Engineering, Biomedical

Multiphasic scaffolds for the repair of osteochondral defects: Outcomes of preclinical studies

Rouyan Chen, Jasmine Sarah Pye, Jiarong Li, Christopher B. Little, Jiao Jiao Li

Summary: Osteochondral defects result in damage to both articular cartilage and subchondral bone, leading to irreversible joint damage and a higher risk of osteoarthritis. Current treatments only address symptoms and are not curative, necessitating the development of tissue engineering solutions. Scaffold-based approaches, using biomaterials tailored to cartilage and bone properties, show promising results in regenerating osteochondral tissue and minimizing further degeneration.

BIOACTIVE MATERIALS (2023)

No Data Available